Diversity and Inclusion Awards

Applications Open June 1

In June 2020, ASGCT made a commitment to promoting justice and equity in gene and cell therapy research. These new funding opportunities include the creation of the Society’s first two fellowship awards, which will support underrepresented populations, including minorities, in gene and cell therapy, and the introduction of an award in support of research on conditions disproportionately impacting minority populations.

Funding Opportunities

Underrepresented Minority Fellowship Award in Gene and Cell Therapy for Oncology

This $100,000 award supports one ASGCT member from an underrepresented minority population as defined by the NIH in a postdoctoral or early-stage investigator with a fellowship in gene or cell therapy-related research for an oncology indication for one year, from September 2021 to August 2022.

Underrepresented Population Fellowship Award in Gene and Cell Therapy for Any Indication

This $100,000 award will support one ASGCT member from an underrepresented group in the scientific workforce as defined by the NIH through a postdoctoral or early-stage investigator fellowship in any gene or cell therapy-related research for one year, from September 2021 to August 2022. 

Award for Research on Conditions Disproportionately Affecting Minorities

This $50,000 award to support one ASGCT member in gene or cell therapy-related research for conditions disproportionately affecting minorities for one year, from November 2021 to October 2022. ASGCT is committed to addressing disparaties in current treatment pipelines, specifically in the level and breadth of research surrounding conditions that primarily affect minority populations.

2021

ASGCT Policy Summit

September 22-24, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.